Head and neck cancers, Mouth and oropharyngeal cancer
Results
Phase 1
This trial looked at a new vaccine called ADXS11 001. Researchers wanted to see if it was safe to use and could boost the immune system of people who had cancer of the part of the throat just behind the mouth (oropharyngeal cancer). This trial was supported by Cancer Research UK.
Recruitment start: 1 February 2012
Recruitment end: 1 November 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Terence Jones
Aintree University Hospitals NHS Foundation Trust
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Liverpool
This is Cancer Research UK trial number CRUK/10/010
Last reviewed: 04 Mar 2016
CRUK internal database number: 4151